BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 15364543)

  • 1. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
    Shipley JM; Waxman DJ
    Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
    Olsen H; Haldosén LA
    Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis.
    Stephens JM; Morrison RF; Wu Z; Farmer SR
    Biochem Biophys Res Commun; 1999 Aug; 262(1):216-22. PubMed ID: 10448095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
    Zhou YC; Waxman DJ
    J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.
    Maloney EK; Waxman DJ
    Toxicol Appl Pharmacol; 1999 Dec; 161(2):209-18. PubMed ID: 10581215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters.
    Hurst CH; Waxman DJ
    Toxicol Sci; 2003 Aug; 74(2):297-308. PubMed ID: 12805656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
    Park SH; Yamashita H; Rui H; Waxman DJ
    Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
    Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
    Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
    Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
    Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
    Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
    Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression.
    Storz P; Döppler H; Horn-Müller J; Groner B; Pfizenmaier K; Müller G
    Anal Biochem; 1999 Dec; 276(1):97-104. PubMed ID: 10585749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
    Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
    Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT5b down-regulates peroxisome proliferator-activated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain.
    Zhou YC; Waxman DJ
    J Biol Chem; 1999 Oct; 274(42):29874-82. PubMed ID: 10514468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N; Duez H; Fruchart JC; Staels B
    Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
    Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P
    Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.